World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
25361
World Ranking
14202
National Ranking
7188

Overview

Carla J. Greenbaum is affiliated with the Virginia Mason Medical Center in the United States and has a research focus primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans 146 publications in Medicine and 73 in Biochemistry, Genetics and Molecular Biology, with notable contributions to Genetics, Endocrinology, Diabetes and Metabolism, Surgery, Immunology, and Oncology.

Their research topics concentrate heavily on diabetes and related disorders, including diabetes management and research, pancreatic function and diabetes, immune cell function and interaction, T-cell and B-cell immunology, diabetes treatment and management, and pancreatitis pathology and treatment.

Carla J. Greenbaum has published numerous papers in prominent venues. Frequent publication venues include:

  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Diabetes Care
  • Diabetes
  • Diabetologia
  • bioRxiv (Cold Spring Harbor Laboratory)

The scientist's recent papers include:

  • "Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals," 2021, Science Translational Medicine
  • "Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes," 2021, Nature Genetics
  • "Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective," 2022, Diabetes
  • "High residual C-peptide likely contributes to glycemic control in type 1 diabetes," 2020, Journal of Clinical Investigation
  • "Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial," 2023, Diabetes Care

Collaborations have involved a number of frequent co-authors, including:

  • Cate Speake (34 publications)
  • Sandra Lord (25 publications)
  • Andrea K. Steck (17 publications)
  • Linda A. DiMeglio (14 publications)
  • Diane K. Wherrett (14 publications)

Best Publications

  • Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.

    Richard A. Insel;Jessica L. Dunne;Mark A. Atkinson;Jane L. Chiang

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

    Skyler Js;Krischer Jp;Wolfsdorf J;Cowie C

  • Improvement in outcomes of clinical islet transplantation: 1999-2010.

    Franca B. Barton;Michael R. Rickels;Rodolfo Alejandro;Bernhard J. Hering

  • C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21–22 October 2001

    Jerry P. Palmer;G. Alexander Fleming;Carla J. Greenbaum;Kevan C. Herold

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Identification of tissue-specific cell death using methylation patterns of circulating DNA.

    Roni Lehmann-Werman;Daniel Neiman;Hai Zemmour;Joshua Moss

  • Latent autoimmune diabetes in adults (LADA) should be less latent.

    S Fourlanos;F Dotta;C J Greenbaum;J P Palmer

  • Teplizumab (Anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders

    Kevan C. Herold;Stephen E. Gitelman;Mario R. Ehlers;Peter A. Gottlieb

  • Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes

    Mary Rieck;Adrian Arechiga;Suna Onengut-Gumuscu;Carla Greenbaum

  • Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth

    Catherine Pihoker;Lisa K. Gilliam;Sian Ellard;Dana Dabelea

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

    Anya Schneider;Mary Rieck;Srinath Sanda;Catherine Pihoker

  • Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

    Antoinette Moran;Brian Bundy;Dorothy J. Becker;Linda A. DiMeglio

  • Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

    S. Alice Long;Mary Rieck;Srinath Sanda;Jennifer B. Bollyky

  • Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

    Manuela Battaglia;Simi Ahmed;Mark S. Anderson;Mark A. Atkinson

  • Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects

    S. Alice Long;Karen Cerosaletti;Paul L. Bollyky;Megan Tatum

  • Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data

    C. J. Greenbaum;C. A. Beam;D. Boulware;S. E. Gitelman

  • Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

    Carla J. Greenbaum;Thomas Mandrup-Poulsen;Paula Friedenberg McGee;Tadej Battelino

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

Jerry P. Palmer
Jerry P. Palmer University of Washington
Jay S. Skyler
Jay S. Skyler University of Miami
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Kevan C. Herold
Kevan C. Herold Yale University
Desmond A. Schatz
Desmond A. Schatz University of Florida
Jane H. Buckner
Jane H. Buckner Virginia Mason Medical Center
Linda A. DiMeglio
Linda A. DiMeglio Indiana University
Gerald T. Nepom
Gerald T. Nepom Virginia Mason Medical Center
William W. Kwok
William W. Kwok University of Washington
Antoinette Moran
Antoinette Moran University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a range of online education and career options, especially for those interested in nursing. Many students consider doctorate in nursing education online programs to advance their roles in leadership, research, or academic settings. These programs often offer flexible learning schedules and open doors to higher-level positions within healthcare.

For licensed nurses seeking advancement, cheap rn to bsn online programs provide an affordable way to earn a bachelor’s degree and boost career prospects. Those who are not yet nurses but hold a non-nursing bachelor’s degree may consider entry level msn programs online, which offer a fast track into advanced nursing roles.

If you are concerned about admission requirements or competitiveness, learning about whats the easiest nursing program to get into? can help you identify accessible programs that match your qualifications. Whether you’re entering the field or advancing your career, these online pathways can make your journey into the medical profession more accessible and affordable.

Best Scientists Citing Carla J. Greenbaum

Trending Scientists